Greg Meyers

Bristol Myers Squibb will become the first life sciences company to purchase Nvidia's latest DGX SuperPOD, powered by the newly unveiled Vera Rubin architecture, marking a significant escalation in AI…

Bristol Myers Squibb is expanding its partnership with Nvidia to boost AI computing power for drug discovery, building on its AI Center of Excellence using Nvidia's DGX SuperPOD infrastructure that ha…